Summary
Interleukin-6 (IL-6) is a pleiotropic cytokine thought to play important regulatory roles in immunity, hemopoiesis, and inflammation (reviewed in ref. 1). The generation of IL-6-deficient mice by gene targeting has allowed direct testing of its role in a variety of physiological and pathological conditions. Thus, IL-6 has been shown to favour the resolution of infections and to promote optimal humoral responses to various antigens while at the same time being required for the development of immune-mediated diseases, such as CIA or EAE, as well as of diseases such as osteoporosis and plasmacytomas, caused by improper expansion of specific hematopietic compartments. In addition, IL-6-deficient mice display defective liver acute phase and regenerative responses, improper body weight regulation, impaired neuronal regeneration, and altered nociceptive responses, confirming the pleiotropic nature of this cytokine. This chapter attempts to review the ample literature in the field by trying to rationalize the main conclusions achieved and to highlight the open-ended problems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kishimoto, T. (1989) The biology of interleukin-6. Blood 74, 1 - 10.
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., and Baumann, H. (1987) Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84, 7251 - 7255.
Behrmann, I., Hermanns, H. M., Haan, C., et al. (2000) Signalling of interleukin-6 type cytokines via gp130, leukemia inhibitory factor (LIE) receptor and oncostatin M receptor. Eur. Cytokine Netw. 11, 491 - 492.
Jones, S. A., Horiuchi, S., Topley, N., Yamamoto, N., and Fuller, G. M. (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15, 43 - 58.
Hirano, T., Nakajima, K., and Hibi, M. (1997) Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8, 241 - 252.
Kopf, M., Baumann, H., Freer, G., et al. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339 - 342.
Poli, V., Balena, R., Fattori, E., et al. (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189 - 1196.
Dalrymple, S. A., Lucian, L. A., Slattery, R., et al. (1995) Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63, 2262 - 2268.
Bernad, A., Kopf, M., Kulbacki, R., Weich, N., Koehler, G., and Gutierrez-Ramos, J. C. (1994) Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1, 725 - 731.
Houssiau, F. and Van Snick, J. (1992) IL6 and the T-cell response. Res. Immunol. 143, 740 - 743.
Uyttenhove, C., Coulie, P. G., and Van Snick, J. (1988) T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J. Exp. Med. 167, 1417 - 1427.
Lotz, M., Jirik, F., Kabouridis, P., et al. (1988) B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med. 167, 1253 - 1258.
Ramsay, A. J. and Kopf, M. (1998) IL-6 knockout mice. In: Durum, S., Kopf, M., and Muegge, K., ed. Cytokine Knockouts. Humana, Totowa, NJ, pp. 227 - 236.
Kopf, M., Herren, S., Wiles, M. V., Pepys, M. B., and Kosco-Vilbois, M. H. (1998) Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J. Exp. Med. 188, 1895 - 1906.
Ramsay, A. J., Ruby, J., and Ramshaw, I. A. (1993) A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14, 155 - 157.
Kishimoto, T. and Hirano, T. (1988) Molecular regulation of B lymphocyte response. Annu. Rev. Immunol. 6, 485 - 512.
Jourdan, M., Bataille, R., Seguin, J., Zhang, X. G., Chaptal, P. A., and Klein, B. (1990) Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum. 33, 398 - 402.
Suematsu, S., Matsusaka, T., Matsuda, T., et al. (1992) Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 89, 232 - 235.
Fattori, E., Della Rocca, C., Costa, P., et al. (1994) Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 83, 2570 - 2579.
Fischer, M. B., Ma, M., Goerg, S., et al. (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157, 549 - 556.
La Flamme, A. C. and Pearce, E. J. (1999) The absence of IL-6 does not affect Th2 cell development in vivo, but does lead to impaired proliferation, IL-2 receptor expression, and B cell responses. J. Immunol. 162, 5829 - 5837.
Alonzi, T., Fattori, E., Lazzaro, D., et al. (1998) Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187, 461 - 468.
Ohshima, S., Saeki, Y., Mima, T., et al. (1998) Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. USA 95, 8222 - 8226.
Sasai, M., Saeki, Y., Ohshima, S., et al. (1999) Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum. 42, 1635 - 1643.
Boe, A., Baiocchi, M., Carbonatto, M., Papoian, R., and Serlupi-Crescenzi, O. (1999) Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis. Cytokine 11, 1057 - 1064.
Eugster, H. P., Frei, K., Kopf, M., Lassmann, H., and Fontana, A. (1998) IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28, 2178 - 2187.
Mendel, I., Katz, A., Kozak, N., Ben-Nun, A., and Revel, M. (1998) Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28, 1727 - 1737.
Okuda, Y., Sakoda, S., Bernard, C. C., et al. (1998) IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10, 703 - 708.
Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T. S., and Chen, Y. (1998) IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161, 6480 - 6486.
Romani, L., Mencacci, A., Cenci, E., et al. (1996) Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183, 1345 - 1355.
Richards, H. B., Satoh, M., Shaw, M., Libert, C., Poli, V., and Reeves, W. H. (1998) Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J. Exp. Med. 188, 985 - 990.
Brewer, J. M., Conacher, M., Gaffney, M., Douglas, M., Bluethmann, H., and Alexander, J. (1998) Neither interleukin-6 nor signalling via tumour necrosis factor receptor-1 contribute to the adjuvant activity of alum and Freund's adjuvant. Immunology 93, 41 - 48.
Bromander, A. K., Ekman, L., Kopf, M., Nedrud, J. G., and Lycke, N. Y. (1996) IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J. Immunol. 156, 4290 - 4297.
Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K., Kopf, M., and Kaufmann, S. H. (1997) Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65, 4843 - 4849.
Markine-Goriaynoff, D., Nguyen, T. D., Bigaignon, G., Van Snick, J., and Coutelier, J. P. (2001) Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms. Int. Immunol. 13, 1185 - 1192.
Ramsay, A. J., Husband, A. J., Ramshaw, I. A., et al. (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561 - 563.
Beagley, K. W., Bao, S., Ramsay, A. J., Eldridge, J. H., and Husband, A. J. (1995) IgA production by peritoneal cavity B cells is IL-6 independent: implications for intestinal IgA responses. Eur. J. Immunol. 25, 2123 - 2126.
Bao, S., Husband, A. J., and Beagley, K. W. (1999) B1 B cell numbers and antibodies against phosphorylcholine and LPS are increased in IL-6 gene knockout mice. Cell Immunol. 198, 139 - 142.
VanCott, J. L., Franco, M. A., Greenberg, H. B., et al. (2000) Protective immunity to rotavirus shedding in the absence of interleukin-6: Thl cells and immunoglobulin A develop normally. J. Virol. 74, 5250 - 5256.
Suzuki, Y., Rani, S., Liesenfeld, O., et al. (1997) Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect. Immun. 65, 2339 - 2345.
Jebbari, H., Roberts, C. W., Ferguson, D. J., Bluethmann, H., and Alexander, J. (1998) A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol. 20, 231 - 239.
Williams, D. M., Grubbs, B. G., Darville, T., Kelly, K., and Rank, R. G. (1998) A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect. Immun. 66, 4564 - 4567.
Saunders, B. M., Frank, A. A., Orme, I. M., and Cooper, A. M. (2000) Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect. Immun. 68, 3322 - 3326.
Cenci, E., Mencacci, A., Casagrande, A., Mosci, P., Bistoni, F., and Romani, L. (2001) Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J. Infect. Dis. 184, 610 - 617.
Anguita, J., Rincon, M., Samanta, S., Barthold, S. W., Flavell, R. A., and Fikrig, E. (1998) Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased Lyme arthritis. J. Infect. Dis. 178, 1512 - 1515.
Dalrymple, S. A., Slattery, R., Aud, D. M., Krishna, M., Lucian, L. A., and Murray, R. (1996) Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect. Immun. 64, 3231 - 3235
van Enckevort, F. H., Sweep, C. G., Span, P. N., Netea, M. G., Hermus, A. R., and Kullberg, B. J. (2001) Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice. Eur. Cytokine Netw. 12, 581 - 586.
Moskowitz, N. H., Brown, D. R., and Reiner, S. L. (1997) Efficient immunity against Leishmania major in the absence of interleukin-6. Infect. Immun. 65, 2448 - 2450.
Titus, R. G., DeKrey, G. K., Morris, R. V., and Soares, M. B. (2001) Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease. Infect. Immun. 69, 5189 - 5192.
Mabbott, N. A., Williams, A., Farquhar, C. F., Pasparakis, M., Kollias, G., and Bruce, M. E. (2000) Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J. Virol. 74, 3338 - 3344.
Feldmann, M., Brennan, F. M., and Maini, R. N. (1996) Rheumatoid arthritis. Cell 85, 307 - 310.
Houssiau, F. A., Devogelaer, J. P., Van Damme, J., de Deuxchaisnes, C. N., and Van Snick, J. (1988) Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31, 784 - 788.
De Benedetti, F., Massa, M., Robbioni, P., Ravelli, A., Burgio, G. R., and Martini, A. (1991) Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 34, 1158 - 1163.
Romano, M., Sironi, M., Toniatti, C., et al. (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6, 315 - 325.
Mihara, M., Moriya, Y., Kishimoto, T., and Ohsugi, Y. (1995) Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br. J. Rheumatol. 34, 321 - 325.
Tamura, T., Udagawa, N., Takahashi, N., et al. (1993) Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci. USA 90, 11924 - 11928.
Trentham, D. E., Townes, A. S., and Kang, A. H. (1977) Autoimmunity to type II collagen an experimental model of arthritis. J. Exp. Med. 146, 857 - 868.
Brackertz, D., Mitchell, G. F., and Mackay, I. R. (1977) Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum. 20, 841 - 8450.
Keystone, E. C., Schorlemmer, H. U., Pope, C., and Allison, A. C. (1977) Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum. 20, 1396 - 1401.
Kobayashi, H., Ohshima, S., Nishioka, K., et al. (2002) Antigen induced arthritis (AIA) can be transferred by bone marrow transplantation: evidence that interleukin 6 is essential for induction of AIA. J. Rheumatol. 29, 1176 - 1182.
van de Loo, F. A., Arntz, O. J., and Van den Berg, W. B. (1997) Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis. Cytokine 9, 453 - 462.
de Hooge, A. S., van De Loo, F. A., Arntz, O. J., and van Den Berg, W. B. (2000) Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis. Am. J. Pathol. 157, 2081 - 2091.
Kerlero de Rosbo, N., Milo, R., Lees, M. B., Burger, D., Bernard, C. C., and Ben-Nun, A. (1993) Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92, 2602 - 2608.
Mendel, I., Kerlero de Rosbo, N., and Ben-Nun, A. (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951 - 1959.
Eugster, H. P., Frei, K., Winkler, F., et al. (2001) Superantigen overcomes resistance of IL-6deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway. Eur. J. Immunol. 31, 2302 - 2312.
Campbell, I. L., Abraham, C. R., Masliah, E., et al. (1993) Neurologic disease induced in trans-genic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90, 10061 - 10065.
Raisz, L. G. (1988) Local and systemic factors in the pathogenesis of osteoporosis. N. Engl. J. Med. 318, 818 - 828.
Horowitz, M. C. (1993) Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260, 626 - 627.
Bellido, T., Jilka, R. L., Boyce, B. F., et al. (1995) Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J. Clin. Invest. 95, 2886 - 2895.
Klein, B., Zhang, X. G., Lu, Z. Y., and Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood 85, 863 - 872.
Klein, B., Wijdenes, J., Zhang, X. G., et al. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78, 1198 - 1204.
Potter, M., and Wiener, F. (1992) Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 13, 1681 - 1697.
Degrassi, A., Hilbert, D. M., Rudikoff, S., Anderson, A. O., Potter, M., and Coon, H. G. (1993) In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proc. Natl. Acad. Sci. USA 90, 2060 - 2064.
Dedera, D. A., Urashima, M., Chauhan, D., LeBrun, D. P., Bronson, R. T., and Anderson, K. C. (1996) Interleukin-6 is required for pristane-induced plasma cell hyperplasia in mice. Br. J. Haematol. 94, 53 - 61.
Screpanti, I., Musiani, P., Bellavia, D., et al. (1996) Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J. Exp. Med. 184, 1561 - 1566.
Lattanzio, G., Libert, C., Aquilina, M., et al. (1997) Defective development of pristane-oilinduced plasmacytomas in interleukin-6-deficient BALB/c mice. Am. J. Pathol. 151, 689 - 696.
Hilbert, D. M., Kopf, M., Mock, B. A., Kohler, G., and Rudikoff, S. (1995) Interleukin 6 is essential for in vivo development of B lineage neoplasms. J. Exp. Med. 182, 243 - 248.
Hilbert, D. M., Migone, T. S., Kopf, M., Leonard, W. J., and Rudikoff, S. (1996) Distinct tumori-genic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway. Immunity 5, 81 - 89.
Fausto, N. (2000) Liver regeneration. J. Hepatol. 32, 19 - 31.
Maione, D., Di Carlo, E., Li, W., et al. (1998) Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J. 17, 5588 - 5597.
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., et al. (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274, 1379 - 1383.
Sakamoto, T., Liu, Z., Murase, N., et al. (1999) Mitosis and apoptosis in the liver of interleukin-6deficient mice after partial hepatectomy. Hepatology 29, 403 - 411.
Ledda-Columbano, G. M., Curto, M., Piga, R., et al. (1998) In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene 17, 1039-1044.
Li, W., Liang, X., Leu, J. I., Kovalovich, K., Ciliberto, G., and Taub, R. (2001) Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology 33, 1377 - 1386.
Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., and Taub, R. (2000) Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31, 149 - 159.
Katz, A., Chebath, J., Friedman, J., and Revel, M. (1998) Increased sensitivity of IL-6-deficient mice to carbon tetrachloride hepatotoxicity and protection with an IL-6 receptor-IL-6 chimera. Cytokines Cell. Mol. Ther. 4, 221 - 227.
Ezure, T., Sakamoto, T., Tsuji, H., et al. (2000) The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am. J. Pathol. 156, 1627 - 1639.
Camargo, C. A., Jr., Madden, J. F., Gao, W., Selvan, R. S., and Clavien, P. A. (1997) Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26, 1513 - 1520.
Kushner, I. (1982) The phenomenon of the acute phase response. Ann. NYAcad. Sci. 389, 39 - 48.
Won, K., Campos, S.P., and Baumann, H. (1993) Experimental systems for studying hepatic acute phase response. In: Mackiewicz, A., Kushner, I., and Baumann, H., ed. Acute Phase Protein. CRC Press, Boca Raton FL, pp. 255 - 271.
Koj, A., Gauldie, J., and Baumann, H. (1993) Biological perspectives of cytokine and hormone networks. In: Mackiewicz, A., Kushner, I., and Baumann, H., ed. Acute Phase Protein. CRC Press, Boca Raton, FL, pp. 275 - 287.
Beutler, B., Milsark, I. W., and Cerami, A. C. (1985) Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869 - 871.
Zetterstrom, M., Sundgren-Andersson, A. K., Ostlund, P., and Bartfai, T. (1998) Delineation of the proinflammatory cytokine cascade in fever induction. Ann. NYAcad. Sci. 856, 48 - 52.
Fattori, E., Cappelletti, M., Costa, P., et al. (1994) Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180, 1243 - 1250.
Xing, Z., Gauldie, J., Cox, G., et al. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311 - 320.
Baumann, H., Ziegler, S. F., Mosley, B., Morella, K. K., Pajovic, S., and Gearing, D. P. (1993) Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells. J. Biol. Chem. 268, 8414 - 8417.
Alonzi, T., Fattori, E., Cappelletti, M., Ciliberto, G., and Poli, V. (1998) Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice. Cytokine 10, 13 - 18.
Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., and Poli, V. (2001) Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol. Cell Biol. 21, 1621 - 1632.
Libert, C., Takahashi, N., Cauwels, A., Brouckaert, P., Bluethmann, H., and Fiers, W. (1994) Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur. J. Immunol. 24, 2237 - 2242.
Benigni, F., Fantuzzi, G., Sacco, S., et al. (1996) Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 87, 1851 - 1854.
Kozak, W., Kluger, M. J., Soszynski, D., et al. (1998) IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Ann. NY Acad. Sci. 856, 33 - 47.
Manfredi, B., Sacerdote, P., Gaspani, L., Poli, V., and Panerai, A. E. (1998) IL-6 knock-out mice show modified basal immune functions, but normal immune responses to stress. Brain Behay. Immun. 12, 201 - 211.
Bethin, K. E., Vogt, S. K., and Muglia, L. J. (2000) Interleukin-6 is an essential, corticotropinreleasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc. Natl. Acad. Sci. USA 97, 9317 - 9322.
Venihaki, M., Dikkes, P., Carrigan, A., and Karalis, K. P. (2001) Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J. Clin. Invest. 108, 1159 - 1166.
Andersson, B., Jobin, M., and Olsson, K. (1966) Serotonin and temperature control. Acta Physiol. Scand. 67, 50 - 56.
Kozak, W., Poli, V., Soszynski, D., Conn, C. A., Leon, L. R., and Kluger, M. J. (1997) Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am. J. Physiol. 272, R621 - R630.
Chai, Z., Gatti, S., Toniatti, C., Poli, V., and Bartfai, T. (1996) Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J. Exp. Med. 183, 311 - 316.
Leon, L. R., White, A. A., and Kluger, M. J. (1998) Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am. J. Physiol. 275, R269 - R277.
Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., and Fuller, G. M. (1999) C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J. Exp. Med. 189, 599 - 604.
Di Santo, E., Alonzi, T., Poli, V., et al. (1997) Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6-deficient mice. Cytokine 9, 300 - 306.
Di Santo, E., Alonzi, T., Fattori, E., et al. (1996) Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production. Brain Res. 740, 239 - 244.
Penkowa, M., Moos, T., Carrasco, J., et al. (1999) Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25, 343 - 357.
Penkowa, M., Giralt, M., Carrasco, J., Hadberg, H., and Hidalgo, J. (2000) Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6deficient mice. Glia 32, 271 - 285.
Swartz, K. R., Liu, F., Sewell, D., et al. (2001) Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 896, 86 - 95.
Klein, M. A., Moller, J. C., Jones, L. L., Bluethmann, H., Kreutzberg, G. W., and Raivich, G. (1997) Impaired neuroglial activation in interleukin-6 deficient mice. Glia 19, 227 - 233.
Murphy, P. G., Borthwick, L. S., Johnston, R. S., Kuchel, G., and Richardson, P. M. (1999) Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons. J. Neurosci. 19, 3791 - 3800.
Galiano, M., Liu, Z. Q., Kalla, R., et al. (2001) Interleukin-6 (IL6) and cellular response to facial nerve injury: effects on lymphocyte recruitment, early microglial activation and axonal outgrowth in IL6-deficient mice. Eur. J. Neurosci. 14, 327 - 341.
Zhong, J., Dietzel, I. D., Wahle, P., Kopf, M., and Heumann, R. (1999) Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice. J. Neurosci. 19, 4305 - 4313.
Xu, X. J., Hao, J. X., Andell-Jonsson, S., Poli, V., Bartfai, T., and Wiesenfeld-Hallin, Z. (1997) Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine 9, 1028 - 1033.
Bianchi, M., Maggi, R., Pimpinelli, F., et al. (1999) Presence of a reduced opioid response in interleukin-6 knock out mice. Eur. J. Neurosci. 11, 1501 - 1507.
Wallenius, V., Wallenius, K., Ahren, B., et al. (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8, 75 - 79.
Lyons, R. E., Anthony, J. P., Ferguson, D. J., et al. (2001) Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect. Immun. 69, 2589 - 2595.
Fenton, R. R., Molesworth-Kenyon, S., Oakes, J. E., and Lausch, R. N. (2002) Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest. Ophthalmol. Vis. Sci. 43, 737 - 743.
van Enckevort, F. H., Netea, M. G., Hermus, A. R., et al. (1999) Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med. Mycol. 37, 419 - 426.
van der Poll, T., Keogh, C. V., Guirao, X., Buurman, W. A., Kopf, M., and Lowry, S. F. (1997) Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis. 176, 439 - 444.
Balto, K., Sasaki, H., and Stashenko, P. (2001) Interleukin-6 deficiency increases inflammatory bone destruction. Infect. Immun. 69, 744 - 750.
Wang, J., Homer, R. J., Chen, Q., and Elias, J. A. (2000) Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J. Immunol. 165, 4051 - 4061.
Leemans, J. C., Vervoordeldonk, M. J., Florquin, S., Van Kessel, K. P., and Van Der Poll, T. (2002) Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am. J. Respir. Crit. Care Med. 165, 1445 - 1450.
Rijneveld, A. W., van den Dobbelsteen, G. P., Florquin, S., et al. (2002) Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J. Infect. Dis. 185, 123 - 126.
Rosenbaum, J. T., Kievit, P., Han, Y. B., Park, J. M., and Planck, S. R. (1998) Interleukin-6 does not mediate endotoxin-induced uveitis in mice: studies in gene deletion animals. Invest. Ophthalmol. Vis. Sci. 39, 64 - 69.
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., et al. (2001) Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14, 705 - 714.
Cuzzocrea, S., De Sarro, G., Costantino, G., et al. (1999) IL-6 knock-out mice exhibit resistance to splanchnic artery occlusion shock. J. Leukoc. Biol. 66, 471 - 480.
Meng, Z. H., Dyer, K., Billiar, T. R., and Tweardy, D. J. (2001) Essential role for IL-6 in post-resuscitation inflammation in hemorrhagic shock. Am. J. Physiol. Cell. Physiol. 280, C343 - C351.
Cuzzocrea, S., Sautebin, L., De Sano, G., et al. (1999) Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J. Immunol. 163, 5094 - 5104.
Cuzzocrea, S., de Sarro, G., Costantino, G., et al. (1999) Role of interleukin-6 in a non-septic shock model induced by zymosan. Eur. Cytokine Netw. 10, 191 - 203.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Poli, V., Maritano, D. (2003). IL-6 Knockout Mice. In: Fantuzzi, G. (eds) Cytokine Knockouts. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-405-4_13
Download citation
DOI: https://doi.org/10.1007/978-1-59259-405-4_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-415-9
Online ISBN: 978-1-59259-405-4
eBook Packages: Springer Book Archive